{"id":"https://openalex.org/W2135456325","doi":"https://doi.org/10.1177/1076029614523490","title":"Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin \u03b1) in Pediatric Patients With Disseminated Intravascular Coagulation","display_name":"Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin \u03b1) in Pediatric Patients With Disseminated Intravascular Coagulation","publication_year":2014,"publication_date":"2014-02-20","ids":{"openalex":"https://openalex.org/W2135456325","doi":"https://doi.org/10.1177/1076029614523490","mag":"2135456325","pmid":"https://pubmed.ncbi.nlm.nih.gov/24563247"},"language":"en","primary_location":{"id":"doi:10.1177/1076029614523490","doi":"https://doi.org/10.1177/1076029614523490","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1076029614523490","pdf_url":null,"source":{"id":"https://openalex.org/S8942861","display_name":"Clinical and Applied Thrombosis/Hemostasis","issn_l":"1076-0296","issn":["1076-0296","1938-2723"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Applied Thrombosis/Hemostasis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112150507","display_name":"Akira Shirahata","orcid":"https://orcid.org/0009-0007-5487-9427","observed_orcids":["https://orcid.org/0009-0007-5487-9427"]},"institutions":[{"id":"https://openalex.org/I188700360","display_name":"University of Occupational and Environmental Health Japan","ror":"https://ror.org/020p3h829","country_code":"JP","type":"education","lineage":["https://openalex.org/I188700360"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Akira Shirahata","raw_affiliation_strings":["University of Occupational and Environmental Health, Japan, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Occupational and Environmental Health, Japan, Fukuoka, Japan","institution_ids":["https://openalex.org/I188700360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012340452","display_name":"Jun Mimuro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146500386","display_name":"Jichi Medical University","ror":"https://ror.org/010hz0g26","country_code":"JP","type":"education","lineage":["https://openalex.org/I146500386"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jun Mimuro","raw_affiliation_strings":["Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, School of Medicine, Tochigi, Japan","The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, School of Medicine, Tochigi, Japan","institution_ids":["https://openalex.org/I146500386"]},{"raw_affiliation_string":"The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113974627","display_name":"Hoyu Takahashi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hoyu Takahashi","raw_affiliation_strings":["Department of Internal Medicine, Niigata Prefectural Kamo Hospital, Niigata, Japan","The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Niigata Prefectural Kamo Hospital, Niigata, Japan","institution_ids":[]},{"raw_affiliation_string":"The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070645906","display_name":"Hajime Tsuji","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hajime Tsuji","raw_affiliation_strings":["Department of Blood Transfusion, Kyoto Prefectural University of Medicine, Kyoto, Japan","The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood Transfusion, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I40677808"]},{"raw_affiliation_string":"The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033446220","display_name":"Isao Kitajima","orcid":"https://orcid.org/0000-0001-6156-4481","observed_orcids":["https://orcid.org/0000-0001-6156-4481"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Isao Kitajima","raw_affiliation_strings":["Department of Clinical Laboratory and Molecular Pathology, Graduate School of Medical and Pharmaceutical Science, University of Toyama, Toyama, Japan","The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Laboratory and Molecular Pathology, Graduate School of Medical and Pharmaceutical Science, University of Toyama, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047434427","display_name":"Tadashi Matsushita","orcid":"https://orcid.org/0000-0002-3646-3125","observed_orcids":["https://orcid.org/0000-0002-3646-3125"]},"institutions":[{"id":"https://openalex.org/I4210090647","display_name":"Nagoya University Hospital","ror":"https://ror.org/008zz8m46","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210090647"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadashi Matsushita","raw_affiliation_strings":["Department of Transfusion Medicine, Nagoya University Hospital, Aichi, Japan","The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Transfusion Medicine, Nagoya University Hospital, Aichi, Japan","institution_ids":["https://openalex.org/I4210090647"]},{"raw_affiliation_string":"The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101955105","display_name":"Yutaka Eguchi","orcid":"https://orcid.org/0000-0002-6905-167X","observed_orcids":["https://orcid.org/0000-0002-6905-167X"]},"institutions":[{"id":"https://openalex.org/I160046202","display_name":"Shiga University of Medical Science","ror":"https://ror.org/00d8gp927","country_code":"JP","type":"education","lineage":["https://openalex.org/I160046202"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yutaka Eguchi","raw_affiliation_strings":["Critical and Intensive Care Medicine, Shiga University of Medical Science, Shiga, Japan","The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Critical and Intensive Care Medicine, Shiga University of Medical Science, Shiga, Japan","institution_ids":["https://openalex.org/I160046202"]},{"raw_affiliation_string":"The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103083005","display_name":"Naoya Kitamura","orcid":"https://orcid.org/0000-0003-2570-746X","observed_orcids":["https://orcid.org/0000-0003-2570-746X"]},"institutions":[{"id":"https://openalex.org/I4210102907","display_name":"Asahi Kasei (Japan)","ror":"https://ror.org/018wp0236","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210102907"]},{"id":"https://openalex.org/I4405274850","display_name":"Asahi Kasei Therapeutics Corporation (Japan)","ror":"https://ror.org/02fy54p06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoya Kitamura","raw_affiliation_strings":["ART Project, Pharmaceutical Sales Division, Asahi Kasei Pharma Corporation, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ART Project, Pharmaceutical Sales Division, Asahi Kasei Pharma Corporation, Tokyo, Japan","institution_ids":["https://openalex.org/I4210102907","https://openalex.org/I4405274850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046412161","display_name":"Goichi Honda","orcid":"https://orcid.org/0000-0002-4916-7640","observed_orcids":["https://orcid.org/0000-0002-4916-7640"]},"institutions":[{"id":"https://openalex.org/I4210102907","display_name":"Asahi Kasei (Japan)","ror":"https://ror.org/018wp0236","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210102907"]},{"id":"https://openalex.org/I4405274850","display_name":"Asahi Kasei Therapeutics Corporation (Japan)","ror":"https://ror.org/02fy54p06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Goichi Honda","raw_affiliation_strings":["ART Project, Pharmaceutical Sales Division, Asahi Kasei Pharma Corporation, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ART Project, Pharmaceutical Sales Division, Asahi Kasei Pharma Corporation, Tokyo, Japan","institution_ids":["https://openalex.org/I4210102907","https://openalex.org/I4405274850"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043470607","display_name":"Yoichi Sakata","orcid":"https://orcid.org/0000-0002-9625-4966","observed_orcids":["https://orcid.org/0000-0002-9625-4966"]},"institutions":[{"id":"https://openalex.org/I146500386","display_name":"Jichi Medical University","ror":"https://ror.org/010hz0g26","country_code":"JP","type":"education","lineage":["https://openalex.org/I146500386"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoichi Sakata","raw_affiliation_strings":["Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, School of Medicine, Tochigi, Japan","The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, School of Medicine, Tochigi, Japan","institution_ids":["https://openalex.org/I146500386"]},{"raw_affiliation_string":"The Japanese Society on Thrombosis and Hemostasis Post-Marketing Surveillance Committee for Recomodulin Injection, Tokyo, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5112150507"],"corresponding_institution_ids":["https://openalex.org/I188700360"],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":null,"fwci":0.6364,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.73121369,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"20","issue":"5","first_page":"465","last_page":"472"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.7778000235557556,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.7778000235557556,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.10779999941587448,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.027899999171495438,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-human-soluble-thrombomodulin","display_name":"recombinant human soluble thrombomodulin","score":0.9049999713897705},{"id":"https://openalex.org/keywords/disseminated-intravascular-coagulation","display_name":"disseminated intravascular coagulation","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.9509999752044678},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.9449999928474426},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.8930000066757202},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7590000033378601},{"id":"https://openalex.org/keywords/survival-rate","display_name":"survival rate","score":0.6050000190734863},{"id":"https://openalex.org/keywords/drug-safety-and-effectiveness","display_name":"drug safety and effectiveness","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8731901049613953},{"id":"https://openalex.org/C201267052","wikidata":"https://www.wikidata.org/wiki/Q414446","display_name":"Thrombomodulin","level":4,"score":0.8379577398300171},{"id":"https://openalex.org/C2778734968","wikidata":"https://www.wikidata.org/wiki/Q823027","display_name":"Disseminated intravascular coagulation","level":2,"score":0.8239871263504028},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.647141695022583},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.629684329032898},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5040349364280701},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.48804083466529846},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4655996263027191},{"id":"https://openalex.org/C2779936836","wikidata":"https://www.wikidata.org/wiki/Q890200","display_name":"Coagulopathy","level":2,"score":0.42359495162963867},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3917369842529297},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3583991229534149},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34394553303718567},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.17447030544281006},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004211","descriptor_name":"Disseminated Intravascular Coagulation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018180","descriptor_name":"Thrombomodulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/1076029614523490","doi":"https://doi.org/10.1177/1076029614523490","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1076029614523490","pdf_url":null,"source":{"id":"https://openalex.org/S8942861","display_name":"Clinical and Applied Thrombosis/Hemostasis","issn_l":"1076-0296","issn":["1076-0296","1938-2723"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Applied Thrombosis/Hemostasis","raw_type":"journal-article"},{"id":"pmid:24563247","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24563247","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320312288","display_name":"Asahi Kasei Pharma Corporation","ror":"https://ror.org/018wp0236"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W335124151","https://openalex.org/W1566182873","https://openalex.org/W1589757596","https://openalex.org/W1971690824","https://openalex.org/W1980107879","https://openalex.org/W1995668765","https://openalex.org/W1998595373","https://openalex.org/W2010344521","https://openalex.org/W2013941311","https://openalex.org/W2027093124","https://openalex.org/W2033569021","https://openalex.org/W2063699843","https://openalex.org/W2083334841","https://openalex.org/W2157199674","https://openalex.org/W2160414927","https://openalex.org/W2161052497","https://openalex.org/W2331697328","https://openalex.org/W2404361268","https://openalex.org/W2568520362"],"related_works":["https://openalex.org/W2754393562","https://openalex.org/W1980107879","https://openalex.org/W2033145523","https://openalex.org/W2118999793","https://openalex.org/W1145421247","https://openalex.org/W2013941311","https://openalex.org/W2418052170","https://openalex.org/W2579493904","https://openalex.org/W1544617007","https://openalex.org/W2893293462"],"abstract_inverted_index":{"Recombinant":[0],"human":[1],"soluble":[2],"thrombomodulin":[3],"(thrombomodulin":[4],"\u03b1":[5],"[TM-\u03b1])":[6],"has":[7,26],"been":[8,27],"marketed":[9],"as":[10],"a":[11],"novel":[12],"anticoagulant":[13],"for":[14,63,120,150],"disseminated":[15],"intravascular":[16],"coagulation":[17],"(DIC)":[18],"in":[19,40,54,85,111,155],"Japan":[20],"since":[21,29],"2008.":[22],"Postmarketing":[23],"surveillance":[24],"(PMS)":[25],"conducted":[28],"its":[30,130],"approval.":[31],"As":[32],"effectiveness":[33,121],"and":[34,48,69,122,136,158],"safety":[35],"were":[36,67,109,118],"not":[37],"previously":[38],"determined":[39],"pediatric":[41,56,65,157],"patients,":[42],"this":[43,125],"study":[44,126],"evaluated":[45],"PMS":[46],"data":[47,62],"examined":[49],"the":[50,78,88,94,98,151],"usefulness":[51],"of":[52,87,105,142,153],"TM-\u03b1":[53,80,96,145],"treating":[55],"DIC.":[57],"After":[58],"excluding":[59],"newborn":[60],"infants,":[61],"210":[64],"patients":[66,113],"analyzed":[68],"compared":[70],"to":[71,147],"3786":[72],"adult":[73,159],"patients.":[74,89,160],"The":[75],"day":[76],"after":[77,93],"last":[79,95],"administration,":[81,97],"DIC":[82,154],"had":[83],"resolved":[84],"58.5%":[86],"At":[90],"28":[91],"days":[92],"survival":[99],"rate":[100],"was":[101,127],"71.6%.":[102],"Nineteen":[103],"episodes":[104],"adverse":[106],"drug":[107],"reactions":[108],"observed":[110],"11":[112],"but":[114],"no":[115,137],"significant":[116],"differences":[117],"noted":[119],"safety.":[123],"Although":[124],"limited":[128],"by":[129],"retrospective":[131],"design,":[132],"including":[133],"selection":[134],"biases":[135],"limitation":[138],"on":[139],"concomitant":[140],"use":[141],"other":[143],"anticoagulants,":[144],"appears":[146],"be":[148],"useful":[149],"treatment":[152],"both":[156]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}